Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ADVB

Advanced Biomed Inc

May 29 • 04:00PM ET

5.01

+1.10 28.13 %

Healthcare • Diagnostics & Research • Taiwan • Nano • NASD

May 29, 2:01 PMRetail momentum in low-float ADVB drives 33.5% intraday surge

Peers: BIAF ISPC NDRA NOTV MBAI XWEL MDXH PRPO QUCY XGN

Scroll to Statements

Index	-	P/E	31.47	EPS (ttm)	0.16	Insider Own	57.77%	Shs Outstand	1.38M	Perf Week	21.31%
Market Cap	6.92M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.58M	Perf Month	-5.47%
Enterprise Value	6.86M	PEG	-	EPS next Q	-	Inst Own	0.10%	Short Float	0.64%	Perf Quarter	23.33%
Income	0.17M	P/S	-	EPS this Y	-	Inst Trans	-0.01%	Short Ratio	0.01	Perf Half Y	-40.36%
Sales	0.00M	P/B	24.04	EPS next Y	-	ROA	59.90%	Short Interest	0.00M	Perf YTD	-14.15%
Book/sh	0.21	P/C	86.50	EPS next 5Y	-	ROE	84.61%	52W High	24.00 -79.12%	Perf Year	-77.43%
Cash/sh	0.06	P/FCF	-	EPS past 3/5Y	10.67% -12.01%	ROIC	58.89%	52W Low	3.61 38.78%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	15.65% 15.49%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	271.18%	Oper. Margin	-	ATR (14)	0.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.38	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.84	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	7.38	EPS Q/Q	69.15%	SMA20	-0.17%	Beta	0.38	Target Price	-
Payout	-	Debt/Eq	0.07	Sales Q/Q	-	SMA50	-2.03%	Rel Volume	0.51	Prev Close	3.91
Employees	31	LT Debt/Eq	0.00	Earnings	-	SMA200	-27.42%	Avg Volume	560.32K	Price	5.01
IPO	Mar 06, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	283,131	Change	28.13%

Feb-18-26 07:00AM	Advanced Biomed Inc. Announces 1 for 20 Share Consolidation (GlobeNewswire) -10.69%
Feb-13-26 08:00AM	Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire)
Dec-31-25 10:25AM	Advanced Biomed sells Hong Kong subsidiary for $23,000 (TipRanks) -13.82%
Dec-30-25 10:17AM	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary (GlobeNewswire)
Sep-19-25 08:30AM	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery (GlobeNewswire) -17.18%
12:29PM	Loading…
Mar-07-25 12:29PM	Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering (GlobeNewswire)
Mar-06-25 09:02AM	Advanced Biomed Inc. Announces Pricing of Initial Public Offering (GlobeNewswire)

Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. It engages in the research & development of microfluidic biochip technologies and provides tumor diagnosis and treatment technology applications. The company was founded by Yi Lu and Steven I-Fang Cheng in 2014 and is headquartered in Tainan, Taiwan.

CEO & ChairmanDr. Yi Lu Ph.D.

CFO & DirectorMr. Mingze Yin

Director of Investor Relations- Alan

SecretaryDr. Hung To Pau Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADVB

Advanced Biomed Inc

Upgrade your Finviz experience